Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin.

نویسندگان

  • Nicola J Mutch
  • Ruchira Engel
  • Shirley Uitte de Willige
  • Helen Philippou
  • Robert A S Ariëns
چکیده

Activated platelets secrete a negatively charged polymer, polyphosphate (polyP). Here, we explore the interactions of polyP with fibrin(ogen) and its effect on fibrin structure and fibrinolysis. Electrophoretic mobility and binding assays indicate that polyP interacts with fibrinogen and soluble fibrin. Clots formed in the presence of polyP exhibited reduced turbidity and permeability indicative of a tighter fibrin network, but these changes were not related to cross-linking or fibrinopeptide release. Microscopy showed a change in fibrin distribution in clots formed with polyP; with formation of tight aggregates of fibrin fibers interspaced with large pores in contrast to homogenous fiber distribution in control clots. Lysis by tissue plasminogen activator (tPA) and plasminogen or plasmin was delayed in clots formed with polyP and depended on both the activator and polyP concentration. Adding polyP to the clot after fibrin formation or to repolymerizing soluble fibrin did not affect lysis, indicating changes induced by polyP occur at the level of conversion of fibrinogen to fibrin. Surface plasmon resonance showed that the presence of polyP reduced the binding of both plasminogen and tPA to partially lysed fibrin surfaces. These data show that polyP directly influences fibrin architecture and attenuates fibrinolysis through reduced binding of fibrinolytic proteins.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

THROMBOSIS AND HEMOSTASIS A delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin

Alzheimer disease is characterized by the presence of increased levels of the amyloid peptide (A ) in the brain parenchyma and cerebral blood vessels. This accumulated A can bind to fibrin(ogen) and render fibrin clots more resistant to degradation. Here, we demonstrate that A 42 specifically binds to fibrin and induces a tighter fibrin network characterized by thinner fibers and increased resi...

متن کامل

Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.

Alzheimer disease is characterized by the presence of increased levels of the β-amyloid peptide (Aβ) in the brain parenchyma and cerebral blood vessels. This accumulated Aβ can bind to fibrin(ogen) and render fibrin clots more resistant to degradation. Here, we demonstrate that Aβ(42) specifically binds to fibrin and induces a tighter fibrin network characterized by thinner fibers and increased...

متن کامل

THE KINETICS OF TAFIa-CATALYZED CLEAVAGE OF CARBOXY TERMINAL LYSINE RESIDUES OF FIBRIN DEGRADATION PRODUCTS AND REMOVAL OF PLASMINOGEN BINDING SITES

Partial digestion of fibrin by plasmin exposes C-terminal lysine residues which comprise new binding sites for both plasminogen and tissuetype plasminogen activator (tPA). This binding increases the catalytic efficiency of plasminogen activation 3000-fold compared to tPA alone. TAFIa attenuates fibrinolysis by removing these residues, which causes a 97% reduction in tPA catalytic efficiency. Th...

متن کامل

مراقبتهای پرستاری دردرمان با فعال کننده پلاسمینوژن بافتی

The main therapeutic objective of emergency after acute myocardial infarction (MI) is limiting the infarcted area through the opening of occluded artery, decreasing demand of myocardial oxygen and preventing MI complications.When arterial wall is injured, the collagen tissue is exposed to platelet aggregation that leads to releasing adenosine 5 diphosphate and subsequent to it, platelet adhesio...

متن کامل

Fibrin affinity of erythrocyte-coupled tissue-type plasminogen activators endures hemodynamic forces and enhances fibrinolysis in vivo.

Plasminogen activators (PAs; e.g., tissue-type, tPA) coupled to red blood cells (RBCs) display in vivo features useful for thromboprophylaxis: prolonged circulation, minimal extravasation, and preferential lysis of nascent versus preexisting clots. Yet, factors controlling the activity of RBC-bound PAs in vivo are not defined and may not mirror the profile of soluble PAs. We tested the role of ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Blood

دوره 115 19  شماره 

صفحات  -

تاریخ انتشار 2010